BioTelemetry, Inc., a mobile and wireless medical technology company, provides cardiac and mobile blood glucose monitoring (BGM), centralized medical imaging, and original equipment manufacturing services for the healthcare and clinical research industries. It operates in three segments: Healthcare, Research, and Technology. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry service; and event monitoring services to prescribe wireless event, digital loop event, memory loop event, and non-loop event monitors. It also provides Holter and extended-wear Holter monitors, and pacemaker and international normalized ratio monitoring services to cardiologists and electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, including cardiac monitoring, imaging, scientific consulting, and data management services for drug, medical treatment, and device trials to pharmaceutical companies and contract research organizations. This segment's centralized services comprise ECG, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The Technology segment focuses on the manufacture, engineering, and development of non-invasive cardiac monitors for healthcare companies, clinics, and hospitals worldwide. This segment offers various devices that include event monitors, digital Holter monitors, and mobile cardiac telemetry monitors, as well as a wireless BGM system. BioTelemetry, Inc. is headquartered in Malvern, Pennsylvania.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:BEAT
CUSIPN/A
Phone610-729-7000
Debt
Debt-to-Equity Ratio0.72
Current Ratio2.29
Quick Ratio2.12
Price-To-Earnings
Trailing P/E Ratio54.96
Forward P/E Ratio35.30
P/E Growth4.26
Sales & Book Value
Annual Sales$286.78 million
Price / Sales6.10
Cash Flow$1.5475 per share
Price / Cash34.45
Book Value$7.70 per share
Price / Book6.92
Profitability
EPS (Most Recent Fiscal Year)$0.97
Net Income$-15,950,000.00
Net Margins-0.39%
Return on Equity18.02%
Return on Assets8.90%
Miscellaneous
Employees1,600
Outstanding Shares32,790,000
Market Cap$2.11 billion
